~30 spots leftby Apr 2026

Escape for Smoking

Recruiting in Palo Alto (17 mi)
+1 other location
ME
Overseen byMary E Cooley, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Dana-Farber Cancer Institute
No Placebo Group

Trial Summary

What is the purpose of this trial?

This is a research study, is testing a program to improve lung health through smoking cessation and providing education around lung screening. In this research study involves Studying the Enhanced Smoking Cessation Approaches to Promote Empowerment (ESCAPE) program compared to usual care. The ESCAPE program was developed help women with HIV quit smoking. Women in the ESCAPE program quit smoking and stayed quit for longer (up to 3 months). For this study, investigators have added a lung screening to the ESCAPE program and want to test if this will improve lung health through increasing quit rates and lung screening. .

Research Team

ME

Mary E Cooley, PhD

Principal Investigator

Dana-Farber Cancer Institute

Eligibility Criteria

This trial is for high-risk smokers aged 55-77 who smoke at least 5 cigarettes a day and have a history of heavy smoking (≥30 pack years). Participants must be English-speaking, own a mobile phone with video call capability, have active health insurance, and can complete an interview. They should not have had lung cancer or low-dose CT screening before.

Inclusion Criteria

Own a mobile phone with access to a video call application
I am between 55 and 77 years old.
≥ 30 pack year smoking history
See 9 more

Exclusion Criteria

I am unable to give consent for medical procedures.
Hospitalization for severe mental illness within the last year
I am under 18 years old.
See 2 more

Treatment Details

Interventions

  • ESCAPE (Behavioural Intervention)
  • Standard Care (Behavioural Intervention)
Trial OverviewThe study compares the ESCAPE program—a smoking cessation approach that includes education on lung screening—to standard care. The goal is to see if adding lung screening information helps people quit smoking more effectively and improves their overall lung health.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Standard CareExperimental Treatment1 Intervention
The usual care program will include 1 counseling session, nicotine replacement therapy at no cost referral and enrollment in quitworks and an educational brochure about lung cancer screening
Group II: EscapeExperimental Treatment1 Intervention
The ESCAPE program provides 8 counseling sessions over the phone, provides nicotine replacement therapy at no cost, and education about lung screening

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dana-Farber Cancer Institute

Lead Sponsor

Trials
1,128
Recruited
382,000+
Dr. Benjamin L. Ebert profile image

Dr. Benjamin L. Ebert

Dana-Farber Cancer Institute

Chief Executive Officer

MD from Harvard Medical School, PhD from Oxford University

Dr. Craig A. Bunnell profile image

Dr. Craig A. Bunnell

Dana-Farber Cancer Institute

Chief Medical Officer since 2012

MD from Harvard Medical School, MPH from Harvard School of Public Health, MBA from MIT Sloan School of Management

American Association for Cancer Research

Collaborator

Trials
9
Recruited
830+